Mimedx (MDXG) Operating Income Growth (3y) (2014 - 2026)
Mimedx (MDXG) Operating Income Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - | 16.96% |
| 2 | Nanobiotix | 1,910.87 Bn | 1,910.81 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 38.78% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 13.47% |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.14 Bn | 3.31 Bn | -12.10% |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn | 69.02% |
| 9 | Revolution Medicines | 37.46 Bn | 37.46 Bn | - | - |
| 10 | Mimedx | 643.51 Mn | 483.74 Mn | 41.62 Mn | -261.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -261.40% |
| Dec 31, 2025 | 23.06% |
| Sep 30, 2025 | 72.40% |
| Jun 30, 2025 | 48.64% |
| Mar 31, 2025 | 42.39% |
| Dec 31, 2024 | 104.90% |
| Sep 30, 2024 | 131.35% |
| Jun 30, 2024 | 289.73% |
| Mar 31, 2024 | 57.76% |
| Dec 31, 2023 | 43.62% |
| Sep 30, 2023 | 46.53% |
| Jun 30, 2023 | 56.74% |
| Mar 31, 2023 | 70.86% |
| Dec 31, 2022 | 62.89% |
| Sep 30, 2022 | -35.73% |
| Jun 30, 2022 | 17.36% |
| Mar 31, 2022 | 11.49% |
| Dec 31, 2021 | 28.94% |
| Sep 30, 2021 | -69.64% |
| Jun 30, 2021 | -30.94% |